CLINICAL TRIALS PROFILE FOR VISINE L.R.
✉ Email this page to a colleague
All Clinical Trials for VISINE L.R.
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04440280 ↗ | Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy | Recruiting | Massachusetts Eye and Ear Infirmary | Phase 2 | 2020-09-16 | This protocol will investigate whether topical application of N-acetyl cysteine (NAC) eye drops decreases oxidative stress and confers cytoprotection in patients with FECD. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VISINE L.R.
Condition Name
Clinical Trial Locations for VISINE L.R.
Trials by Country
Clinical Trial Progress for VISINE L.R.
Clinical Trial Phase
Clinical Trial Sponsors for VISINE L.R.
Sponsor Name